Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 03-31 16:00:00 EDT

71.64

+2.42

+3.49%

High71.74	Low69.22	Vol951.23M
Open69.22	D1 Closing69.22	Amplitude3.65%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O24.41B	T/O Rate--	Tradable Shares0.00
P/B6.682266	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":71.64154,"timestamp":1774987199999,"preClose":69.22381,"halted":0,"volume":951226372,"delay":0,"changeRate":0.034926,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":2.417732,"latestTime":"03-31 16:00:00 EDT","open":69.21666,"high":71.74109,"low":69.21666,"amount":24407403425.441494,"amplitude":0.036468,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775050200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.682266,"peRate":-172.314087,"turnoverRate":0.027841,"increases":462,"decrements":50,"flats":4,"marketCap":1844669156724.6875,"floatMarketCap":1651529169819.6406},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2624599909","title":"Analysts’ Top Healthcare Picks: Sotera Health (SHC), Insmed (INSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624599909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624599909?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:21","pubTimestamp":1775035287,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sotera Health (SHC), Insmed (INSM) and Scholar Rock ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-sotera-health-shc-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-sotera-health-shc-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","INSM","LABU","HCSG","LU0053671581.USD","LU0109394709.USD","LU0128526141.USD","BK4581","BK4585","XLV","LU0889565916.HKD","BK4588","LU0029874061.USD","BK4121","LU0320765992.SGD","XBI","SHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624599186","title":"Caris Life Sciences initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2624599186","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624599186?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:15","pubTimestamp":1775034947,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Caris Life Sciences (CAI) with a Buy rating and $27 price target representing 51% upside. The company can conti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4552","LU1868837300.USD","IE00BSNM7G36.USD","LU0048573561.USD","LU1804176565.USD","BK4139","LU1668664300.SGD","LU2237443978.SGD","LU2265009873.SGD","LU2471134952.CNY","IE0034235188.USD","LU0061475181.USD","BK4104","LU1894683264.USD","LU2237443549.SGD","LU2237443622.USD","LU0345770308.USD","BK4588","CAI","LU1868836757.USD","BK4550","BK4516","BK4504","LU1868837136.USD","IE0002270589.USD","BK4585","GSX","LU0096364046.USD","LU2471134879.HKD","BK4533","IE0004091025.USD","IE00B19Z3581.USD","LU0251131958.USD","LU1868836914.USD","LU1894683348.USD","BK4127","LU0742534661.SGD","LU2237443382.USD","LU2471134796.USD","LU2237443465.HKD","LU2237443895.HKD","LU2750360997.AUD","IE0004086264.USD","LU2471134523.USD","LU0106831901.USD","LU2750360641.GBP","LU1791807156.HKD","LU0345770993.USD","LU2237438978.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624954085","title":"Mink Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2624954085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624954085?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:40","pubTimestamp":1775032817,"startTime":"0","endTime":"0","summary":"Mink Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryMink Therapeutics Inc INKT.OQ reported a quarterly adjusted loss of 56 cents per share for the quarter ended D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nL8N40K0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624593095","title":"SaveLend Group To Apply For Credit Market Company Authorisation In Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2624593095","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624593095?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:22","pubTimestamp":1775031759,"startTime":"0","endTime":"0","summary":"April 1 (Reuters) - SaveLend Group AB ::*BOARD AND MANAGEMENT SEE SIGNIFICANT POTENTIAL IN OBTAINING AUTHORISATION AS CREDIT MARKET COMPANY, VIEW IT AS IMPORTANT STEP IN CO'S LONG-TERM DEVELOPMENT*BOA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nRSD6pb8jr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YTENQ","WUMSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624593659","title":"Octopus AIM VCT 2 Confirms Total Voting Rights at 215.2 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624593659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624593659?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:01","pubTimestamp":1775030516,"startTime":"0","endTime":"0","summary":"Octopus AIM VCT 2 ( ($GB:OSEC) ) has issued an announcement. Octopus AIM VCT 2 plc has confirmed that, as of 31 March 2026, its issued share capita...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/octopus-aim-vct-2-confirms-total-voting-rights-at-215-2-million-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/octopus-aim-vct-2-confirms-total-voting-rights-at-215-2-million-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIM","BK4557","TSS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624502593","title":"SkinBioTherapeutics Shares Suspended on AIM After Interim Results Delay","url":"https://stock-news.laohu8.com/highlight/detail?id=2624502593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624502593?lang=en_us&edition=fundamental","pubTime":"2026-04-01 15:53","pubTimestamp":1775030015,"startTime":"0","endTime":"0","summary":"An update from SkinBioTherapeutics ( ($GB:SBTX) ) is now available. SkinBioTherapeutics said trading in its shares on London’s AIM has been suspend...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/skinbiotherapeutics-shares-suspended-on-aim-after-interim-results-delay?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/skinbiotherapeutics-shares-suspended-on-aim-after-interim-results-delay?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AIM","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624756770","title":"ORIC Pharmaceuticals Stock Nosedives 25% After Hours: What Is Going On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624756770","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624756770?lang=en_us&edition=fundamental","pubTime":"2026-04-01 14:48","pubTimestamp":1775026080,"startTime":"0","endTime":"0","summary":"ORIC Pharmaceuticals stock rose after reporting positive cancer drug data and advancing to a Phase 3 trial, before falling sharply in after-hours trading.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/01/Medication-In-Transparent-Capsules-On-A-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/01/Medication-In-Transparent-Capsules-On-A-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/04/51590748/oric-pharmaceuticals-stock-nosedives-25-percent-after-hours-what-is-going-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51590748/oric-pharmaceuticals-stock-nosedives-25-percent-after-hours-what-is-going-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624564407","title":"FDA Review Uncertainty Puts Cadrenal Therapeutics’ CAD-1005 Phase 3 Timeline and Costs at Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2624564407","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624564407?lang=en_us&edition=fundamental","pubTime":"2026-04-01 14:00","pubTimestamp":1775023212,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc. (CVKD) has disclosed a new risk, in the Innovation / R&D category. Cadrenal Therapeutics, Inc. faces uncertainty becaus...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-review-uncertainty-puts-cadrenal-therapeutics-cad-1005-phase-3-timeline-and-costs-at-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-review-uncertainty-puts-cadrenal-therapeutics-cad-1005-phase-3-timeline-and-costs-at-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4585","BK4539","LABU","BK4588","BK4139","BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624561674","title":"Soligenix Q4 EPS $(0.29) Beats $(0.56) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2624561674","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624561674?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:20","pubTimestamp":1775020806,"startTime":"0","endTime":"0","summary":"Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.56) by 48.75 percent. This is a 74.82 percent increase over losses of $(1.14) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/51590086/soligenix-q4-eps-0-29-beats-0-56-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624387561","title":"Apellis Pharmaceuticals Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $41 From $55","url":"https://stock-news.laohu8.com/highlight/detail?id=2624387561","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624387561?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:10","pubTimestamp":1775020231,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K09C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1093756325.SGD","BK4505","BK4139","BK4588","LU1093756168.USD","APLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624356186","title":"Genmab names Margarida Duarte general manager for Europe and emerging markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2624356186","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624356186?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:07","pubTimestamp":1775020077,"startTime":"0","endTime":"0","summary":"Genmab appointed Margarida Duarte as general manager for Europe and emerging markets as it expands commercial operations in the region.Duarte will lead commercial strategy and execution across those markets, including preparation for upcoming product launches.She most recently served as executive vice president and chief commercial officer at Deciphera Pharmaceuticals, overseeing commercialization in US and Europe.Earlier roles included leadership positions at Alnylam Pharmaceuticals, Exelixis, Onyx Pharmaceuticals, and Amgen.Duarte will be based in Zug and report to Genmab Chief Commercial Officer Brad Bailey.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2CZMzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2089984988.USD","BK4139","IE0002141913.USD","LU0058720904.USD","AMGN","LU1057294990.SGD","LU0868494617.USD","LU0889565916.HKD","LU0882574055.USD","LU2242652126.USD","IE00BJJMRZ35.SGD","BK4599","LU1061106388.HKD","IE00B2B36J28.USD","IE0009355771.USD","BK4588","LU0320765992.SGD","LU1023059063.AUD","LU0114720955.EUR","BK4566","BK4548","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4585","IE00B4R5TH58.HKD","LU0289739699.SGD","SG9999001440.SGD","BK4533","ALNY","LU2468319806.SGD","LU2112291526.USD","LU0122379950.USD","EXEL","LU0109394709.USD","LU1983299246.USD","LU1571399168.USD","BK4532","BK4534","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624569091","title":"PRESS DIGEST -Wall Street Journal - April 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2624569091","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624569091?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:03","pubTimestamp":1775019793,"startTime":"0","endTime":"0","summary":"PRESS DIGEST -Wall Street Journal - April 1April 1 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accurac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nL6N40K0DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORCU","LU0889565833.HKD","LU1489326972.SGD","LU0208291251.USD","BK4507","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0976567544.SGD","LU1852331112.SGD","LU0256863811.USD","LU1035773651.USD","LU2458330243.SGD","LU0444973449.USD","LU1934455277.USD","IE0009356076.USD","LU0719512351.SGD","IE00BBT3K403.USD","APLS","LU0949170772.SGD","LU1935042215.USD","LU0889565916.HKD","LU0210536198.USD","IE0004445239.USD","LU0234570918.USD","IE0002270589.USD","LU1621768206.USD","SNAP","BK4508","LU1548497426.USD","BK4533","LU1621767810.EUR","LU1935042991.SGD","IE00BMPRXN33.USD","LU1989772840.SGD","BK4532","LU0433182093.SGD","LU2746668974.SGD","LU2860962120.EUR","LU1037948541.HKD","LU1815336760.USD","IE00BMPRXR70.SGD","LU0553294199.USD","LU0965509101.SGD","LU2237957811.SGD","LU0314106906.USD","SG9999003800.SGD","LU0348723411.USD","LU0056508442.USD","BK4115","IE00B3S45H60.SGD","BK4585","LU1506573853.SGD","BK4516","IE00BLSP4239.USD","IE00B5949003.HKD","LU1720051017.SGD","LU1934455194.USD","LU0082616367.USD","LU0109394709.USD","ORCL","LU1435385759.SGD","IE00B19Z9Z06.USD","BK4077","BIIB","T","LU1935042488.USD","IE00BFXG1179.USD","LU0149725797.USD","IE00B19Z9P08.USD","LU1366192091.USD","IE00BMPRXQ63.HKD","LU2384288077.EUR","LU1201861249.SGD","LU1366333091.USD","BK4543","LU1621768115.EUR","LU1429558221.USD","LU0878866978.SGD","LU0545039389.USD","LU0211326839.USD","LU2236285917.USD","LU0157215616.USD","BK4576","LU0476273544.USD","LU0130102774.USD","LU0965508806.USD","IE00B775SV38.USD","ORCX","BK4554","LU1003077747.HKD","BK4528","LU1571399168.USD","LU0444971666.USD","ORCS","LU1934455863.HKD","IE00BN8TJ469.HKD","LU0353189680.USD","LU2326559502.SGD","BK4598","LU0957808578.USD","LU2896262040.SGD","SG9999011175.SGD","LU2746668461.USD","BK4534","LU2458330169.SGD","LU1989764664.SGD","BK4505","LU2237957902.USD","LU2360106780.USD","BK4538","LU0496365809.HKD","IE00B7SZLL34.SGD","LU2357305700.SGD","SG9999001424.SGD","LU2087625088.SGD","BK4581","LU0661504455.SGD","LU0861579265.USD","LU2054465674.USD","LU1989772923.USD","BK4551","LU0320765992.SGD","LU0980610538.SGD","BK4550","BK4097","LU0175139822.USD","IE00BSNM7G36.USD","LU0648001328.SGD","LU0198837287.USD","LU2543165471.USD","IE00B19Z3581.USD","BK4139","LU1720051108.HKD","BK4515","BK4588","LU1093756168.USD","LU1621767737.EUR","LU0417517546.SGD","LU1935043536.SGD","LU2108987350.USD","LU1069347547.HKD","LU0081259029.USD","LU2250418816.HKD","LU0068578508.USD","LU0738911758.USD","LU0070302665.USD","LU0109392836.USD","LU1989764748.USD","LU0985489474.SGD","LU1642822529.SGD","LU1803068979.SGD","IE00B894F039.SGD","LU0289960550.SGD","LU0323591593.USD","LU1935043023.USD","LU1037948897.HKD","LU0353189763.USD","IE00BLSP4452.SGD","LU0965509010.AUD","LU1093756325.SGD","LU0211326755.USD","LU0234572021.USD","LU1691799644.USD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164785720","title":"Six-Day Holiday Ignites Travel Enthusiasm: Spring Break Meets Qingming Festival","url":"https://stock-news.laohu8.com/highlight/detail?id=1164785720","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164785720?lang=en_us&edition=fundamental","pubTime":"2026-04-01 12:41","pubTimestamp":1775018482,"startTime":"0","endTime":"0","summary":"April brings blooming flowers and vibrant life. Many years ago, poet Lin Huiyin captured the beauty of this month in her work \"You Are the April of This World,\" describing it as a season of blossoms,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4109","BK4121","DNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624363566","title":"Biogen : Oppenheimer Raises Target Price to $275 From $250","url":"https://stock-news.laohu8.com/highlight/detail?id=2624363566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624363566?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:49","pubTimestamp":1775015393,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40J15N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIIB","BK4585","IE00B19Z9Z06.USD","BK4532","IE00B894F039.SGD","LU0320765992.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","LU0109394709.USD","LU0234570918.USD","BK4533","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624056619","title":"Biogen to Acquire Apellis, Expanding Ophthalmology Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2624056619","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624056619?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:45","pubTimestamp":1775015115,"startTime":"0","endTime":"0","summary":"Biogen ( ($BIIB) ) just unveiled an update. On March 31, 2026, Biogen signed a merger agreement to acquire Apellis Pharmaceuticals via a tender off...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biogen-to-acquire-apellis-expanding-ophthalmology-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biogen-to-acquire-apellis-expanding-ophthalmology-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9P08.USD","LU0320765992.SGD","BK4532","LU0889565916.HKD","LU0234570918.USD","LU0109394709.USD","IE00B894F039.SGD","BK4533","BIIB","BK4139","BK4585","IE00B19Z9Z06.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624565014","title":"Oric Advances Rinzimetostat Toward First Prostate Cancer Phase 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2624565014","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624565014?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:38","pubTimestamp":1775014695,"startTime":"0","endTime":"0","summary":"An announcement from Oric Pharmaceuticals ( ($ORIC) ) is now available. On March 31, 2026, ORIC Pharmaceuticals presented an update on dose optimiz...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oric-advances-rinzimetostat-toward-first-prostate-cancer-phase-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oric-advances-rinzimetostat-toward-first-prostate-cancer-phase-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624565111","title":"Scholar Rock Holding Corp : Raymond James Raises Target Price to $60 From $53","url":"https://stock-news.laohu8.com/highlight/detail?id=2624565111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624565111?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:28","pubTimestamp":1775014082,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40J1AV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624389566","title":"Is Early RAS(ON) Pancreatic Cancer Data Altering The Investment Case For Revolution Medicines (RVMD)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624389566","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624389566?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:24","pubTimestamp":1775013848,"startTime":"0","endTime":"0","summary":"Revolution Medicines recently reported early clinical data showing that its RAS-targeting candidates daraxonrasib and zoldonrasib exhibited activity in second-line metastatic pancreatic cancer, an area with few effective treatments.\nThis progress in directly targeting RAS(ON) via a molecular glue mechanism highlights a differentiated scientific approach in a difficult-to-treat tumor type.\nNext, we will examine how this early pancreatic cancer data, particularly the molecular glue RAS(ON)...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/is-early-rason-pancreatic-cancer-data-altering-the-investmen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/is-early-rason-pancreatic-cancer-data-altering-the-investmen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2298322129.HKD","LU2360107325.USD","IE00BZ199S13.USD","LU1854104046.USD","BK4512","LU1861220033.SGD","BK4585","LU0724618433.USD","LU2357305700.SGD","BK4139","BK4605","LU0348723411.USD","IE00BD6J9T35.USD","LU0124384867.USD","LU1720051108.HKD","LU1854103824.USD","LU1861219969.SGD","LU1548497426.USD","LU1978683503.SGD","RVMD","BK4141","LU1861215975.USD","BK4588","ON","IE00BFMHRM44.USD","LU1861214812.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624566883","title":"A Look At Kodiak Sciences (KOD) Valuation After Zenkuda GLOW2 Phase 3 Success And BLA Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2624566883","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624566883?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:23","pubTimestamp":1775013807,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) is back in focus after reporting that its GLOW2 Phase 3 study of Zenkuda in diabetic retinopathy met key efficacy and safety endpoints, supporting a multi-indication, BLA-ready profile.\nSee our latest analysis for Kodiak Sciences.\nThe Zenkuda update arrives alongside sharp recent moves in the stock, with a 74.46% 7 day share price return and a 42.24% 30 day share price return. The 1 year total shareholder return is very large, suggesting momentum has picked up sharply...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/a-look-at-kodiak-sciences-kod-valuation-after-zenkuda-glow2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/a-look-at-kodiak-sciences-kod-valuation-after-zenkuda-glow2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4505","DCF","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624565579","title":"Apellis Pharmaceuticals Inc : Baird Cuts to Neutral From Outperform; Cuts Target Price to $41 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2624565579","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624565579?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:18","pubTimestamp":1775013513,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40J1IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756168.USD","BK4505","LU1093756325.SGD","BK4585","BK4588","BK4139","APLS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.052},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0282},{"period":"1year","weight":0.1626},{"period":"ytd","weight":-0.0463}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}